All these drugs share the ability to block HIF-VEGF-VEGFR and HIF-PDGF-PDGFR axis that plays a significant role in tumor angiogenesis – their use may partially reverse the effect of pVHL loss of function, leading to tumor regression. This evidence concerns the gene VEGFA and neoplasm.